Par Drugs And Chemicals Limited - Company Profile

It is a chemicals and materials public limited company based in Vadodara, Gujarat, India, established in 1999.
1999 Vadodara, Gujarat, India Active
Last Updated:
Access Report
About Par Drugs And Chemicals Limited

Par Drugs And Chemicals Limited, a active public limited company, was established on 26 February 1999 in Vadodara, Gujarat, India. Engaging in industrial chemicals within the manufacturing sector, it holds CIN: L24117GJ1999PLC035512. Registered under ROC Roc Ahmedabad. it is listed. It has an authorized capital of ₹12.50 Cr and a paid-up capital of ₹12.30 Cr.

Formerly known as Par Drugs And Chemicals Private Limited. It upholds a compliant status. In 2023, it reported revenue of ₹95.99 Cr and a net worth of ₹71.24 Cr. Employing 118 professional, Its leadership includes Krishna Mitulbhai Shah (Director), Kajal Chintanbhai Vaghani (Director), Pravin Manjibhai Bhayani (Director). Past directors included Krishna Mitulbhai Shah, Kajal Chintanbhai Vaghani, Pravin Manjibhai Bhayani. It holds no open charges and ₹103.47 Cr settled loans. Its latest AGM occurred on 27 September 2025, with the balance sheet filed on 31 March 2025. It is based at 815, Nilamber Triumph, Gotri Vasna Road,, Vadodara, Gujarat, 390007.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L24117GJ1999PLC035512

  • Registration Number

    035512

  • Incorporation Date

    26 February 1999

  • Authorized Capital

    ₹12.50 Cr

  • Paid-Up Capital

    ₹12.30 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Listed

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 12.50 Cr
  • Paid Up Capital ₹ 12.30 Cr
  • Company Age 27 Year, 11 Days
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 103.47 Cr
  • Revenue Growth **** 27.54%
  • Profit Growth **** 23.02%
  • Ebitda **** 12.01%
  • Net Worth 18.97%
  • Total Assets **** 12.93%
Company report

Par Drugs And Chemicals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Par Drugs And Chemicals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Par Drugs And Chemicals Limited?
Current Directors
Name Designation Appointment Date Status
Krishna Mitulbhai Shah Director 17 Jan 2019 Current
Kajal Chintanbhai Vaghani Director 17 Jan 2019 Current
Pravin Manjibhai Bhayani Director 17 Jan 2019 Current
Bintal Bhaveshkumar Shah Director 28 Sep 2020 Current
Falgun Vallabhbhai Savani Managing Director 26 Feb 1999 Current
Nayna Jignesh Savani Director 02 Feb 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 09 Feb 2019 Past
Pramod Abcsdd Additional Director 09 Feb 2019 Past
Pramod Abcsdd Additional Director 09 Feb 2019 Past
Pramod Abcsdd Director 20 Dec 2018 Past
Pramod Abcsdd Additional Director 29 Sep 2021 Past
Pramod Abcsdd Director 20 Dec 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Par Drugs And Chemicals.

Par Drugs And Chemicals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.54% increase. The company also saw a substantial improvement in profitability, with a 23.02% increase in profit. The company's net worth Soared by an impressive increase of 18.97%.

Par Drugs And Chemicals revenue growth over time
Par Drugs And Chemicals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 27.54%
*******
*******
*******
*******
Revenue from Operations
*******
 27.54%
*******
*******
*******
*******
Total Assets
*******
 12.93%
*******
*******
*******
*******
Profit or Loss
*******
 23.02%
*******
*******
*******
*******
Net Worth
*******
 18.97%
*******
*******
*******
*******
EBITDA
*******
 12.01%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Par Drugs And Chemicals?

In 2023, Par Drugs And Chemicals had a promoter holding of 74.21% and a public holding of 25.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹1,034,735,000.00

Charges Breakdown by Lending Institutions
  • Union Bank Of India : 75.36 Cr
  • State Bank Of Saurashtra : 10.02 Cr
  • 3I Infotech Trusteeship Services Limited : 9.20 Cr
  • State Bank Of India : 8.39 Cr
  • Others : 0.50 Cr
Latest Charge Details
Date Lender Amount Status
17 Jan 2018 Others ₹5.00 M Satisfied
26 Dec 2011 Union Bank Of India ₹37.68 Cr Satisfied
14 Dec 2011 Union Bank Of India ₹37.68 Cr Satisfied
19 Nov 2011 State Bank Of India ₹1.75 M Satisfied
04 Aug 2009 State Bank Of India ₹7.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Par Drugs And Chemicals?

Par Drugs And Chemicals has a workforce of 118 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Par Drugs And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Par Drugs And Chemicals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Par Drugs And Chemicals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Par Drugs And Chemicals Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Par Drugs And Chemicals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.

  • Charges

    The activity A charge registered on 17 Jan 2018 via Charge ID 100148137 with Others was fully satisfied on 23 Sep 2024. was completed.

  • Charges

    A charge with Others of Rs. 0.50 Cr registered on 17 Jan 2018 with Charge ID 100148137 was modified on 26 Jun 2023. was recorded as a recent event.

  • Director Appointment

    Bintal Bhaveshkumar Shah was appointed as a Director was appointed as a Director on 28 Sep 2020 & has been associated with this company since 5 years 5 months . was recorded as a recent event.

  • Director Appointment

    The activity Jignesh Vallabhbhai Savani was appointed as a Nodal Officer was appointed as a Nodal Officer on 01 Sep 2020 & has been associated with this company since 5 years 6 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Par Drugs And Chemicals Limited?

The CIN of Par Drugs And Chemicals Limited is L24117GJ1999PLC035512.

Where is Par Drugs And Chemicals Limited headquartered?

Par Drugs And Chemicals Limited is headquartered at 815, Nilamber Triumph, Gotri Vasna Road,, Vadodara, Gujarat, 390007.

When was Par Drugs And Chemicals Limited incorporated?

Par Drugs And Chemicals Limited was incorporated on 26 February 1999.

Who are the current directors of Par Drugs And Chemicals Limited?

The current directors of Par Drugs And Chemicals Limited are

What is the primary industry of Par Drugs And Chemicals Limited?

The primary industry of Par Drugs And Chemicals Limited is Manufacturing.

Is Par Drugs And Chemicals Limited a listed company?

Par Drugs And Chemicals Limited is listed.

What is the capital structure of Par Drugs And Chemicals Limited?

The authorized capital of Par Drugs And Chemicals Limited is ₹12.50 Cr, and the paid-up capital is ₹12.30 Cr.

What is the compliance status of Par Drugs And Chemicals Limited?

The compliance status of Par Drugs And Chemicals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available